CNSP Stock Analysis: Buy, Sell, or Hold?
CNSP - CNS Pharmaceuticals, Inc. Common Stock
$4.95
0.06 (1.23%)
▲
5d:
+1.23%
30d:
-1.2%
90d:
+102.04%
BUY
MODERATE Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: May 21, 2026
0d
Get Alerted When CNSP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CNSP shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CNSP shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CNSP is currently trading at $4.95, which is considered fair relative to its 30-day fair value range of $4.58 to $5.98.
Technical Outlook: Technically, CNSP is showing sideways momentum. Immediate support is located at $4.40, while resistance sits at $5.34.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+104.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CNSP is showing sideways momentum. Immediate support is located at $4.40, while resistance sits at $5.34.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+104.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$4.58 -
$5.98
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 104.5% below Wall St target ($10.00)
Trading Range Analysis
30-Day Trading Range
$4.58 -
$5.98
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$4.40
Resistance Level
$5.34
Current Trend
Sideways
Technical data as of
Jun 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.95
Wall Street Target
$10.00
(+104.5%)
Share & Embed Analysis
Last updated: June 15, 2026 11:16 AM ET
Data refreshes hourly during market hours. Next update: 12:16 PM
Data refreshes hourly during market hours. Next update: 12:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNSP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 62 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$256 | 59 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 49 HOLD |
